AXON stock forecast, quote, news & analysis
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions... Show more
Axon Enterprise (AXON) Stock Analysis: AI Momentum Faces Valuation Hurdles
Key Takeaways
- Axon Enterprise's shares have fallen about 30% year-to-date in 2026, reflecting investor caution on high valuations despite strong fundamentals.
- Upcoming Q1 2026 earnings on May 6 are anticipated to demonstrate continued revenue expansion, building on prior software growth.
- New AI tools launched to address public safety data challenges, including an AI co-pilot for 911 calls, bolstering the company's tech moat.
- Analysts maintain a bullish consensus with average price targets around $750, signaling potential upside.
- Software and services revenue surged 40% in the latest quarter, driving annual recurring revenue (ARR, a measure of predictable subscription income) to $1.35 billion.
Current Market Snapshot
In recent weeks, Axon Enterprise (AXON) stock has navigated a notable pullback within the broader market cycle, retreating from earlier highs amid heightened scrutiny of its elevated valuation metrics. Trading in the low $400s after a 52-week range spanning $339 to $886, the shares reflect a year-to-date decline of roughly 30%, contrasting with robust underlying business momentum. The price-to-earnings (P/E) ratio exceeds 260 on a trailing twelve-month (TTM) basis, underscoring the market's growth premium on the public safety technology leader. Average trading volumes persist around 1 million shares daily, as investors weigh AI-driven innovations against profitability and debt concerns in recent sessions.
Trending AI Robots
Tickeron's Trending AI Robots page curates the top 25 performers from a library of over 350 AI trading bots that analyze and trade thousands of tickers across diverse strategies. These bots employ machine learning (ML) models for technical and fundamental analysis, trend following, dip buying, and volatility plays, with timeframes from 5 minutes to 60 minutes. Standouts include bots targeting semiconductors, industrials, and small caps—sectors akin to AXON's domain—with annualized returns ranging from +23% to +163%, win rates of 51% to 88%, and profit factors up to 11.7. For instance, an industrials-focused bot boasts +95% returns and 67% win rate over 60-minute trades, while semiconductor plays average 60%+ wins. Each bot's unique style, from single-agent dip trackers to multi-agent trend traders, adapts to current conditions. Traders can explore these high-confidence options to enhance portfolios amid volatile markets.
Recent Developments Driving AXON Price Action
Axon Enterprise (AXON) has seen choppy price action in recent weeks, with shares dropping around 14-19% over the past month despite solid operational tailwinds. A key catalyst emerged on April 7, when the company unveiled three new AI tools to combat public safety's data overload, including an AI-powered co-pilot for 911 calls designed to transcribe, summarize, and prioritize emergency data. This innovation builds on AXON's expanding ecosystem of body cameras, TASERs (conducted energy weapons), and cloud software, reinforcing its dominance in law enforcement tech. The announcement highlighted potential to reshape incident response, yet failed to stem the sell-off, as investors fretted over execution risks and competition from broader AI plays.
On April 22, AXON confirmed its Q1 2026 earnings release for May 6, following a stellar Q4 2025 where software and services revenue grew 40% year-over-year, propelling total revenue up 33% to $2.8 billion for the year. Annual recurring revenue hit a record $1.35 billion, comprising 43% of total sales—a shift underscoring the high-margin SaaS (software-as-a-service) pivot. Company guidance for 2026 projects 27-30% revenue growth, fueled by AI and cloud bookings. However, the stock dipped sharply earlier in April, including a 10% single-day drop on April 9, amid broader profit-taking after a post-Q4 rally. This extended a year-to-date decline to 30%, with shares hitting near the 52-week low of $339.
Two primary factors have pressured sentiment: soaring valuation, with a TTM P/E of 263 and enterprise value-to-revenue multiple over 11, prompting comparisons to frothy AI peers; and rising debt levels, as total debt-to-equity stands at 59%, amid capital-intensive expansions. Investor searches for AXON spiked recently, signaling interest in the dip, while analysts held firm—no major rating changes in the period, maintaining "Strong Buy" consensus. Macro headwinds like potential government budget constraints on public safety spending added caution, though AXON's 89% gross margins and $230 million levered free cash flow (TTM) provide resilience. Overall, these developments linked a post-growth digestion phase to the pullback, setting the stage for earnings to recalibrate views.
2026 Outlook and Key Factors to Monitor
As Axon Enterprise advances through 2026, investors should track several pivotal themes grounded in recent guidance and market dynamics. The company's 27-30% revenue growth projection hinges on accelerating AI integrations, such as the new 911 tools and cloud platforms, which could expand ARR beyond $1.35 billion by enhancing public safety workflows. Long-term drivers include rising global demand for non-lethal tech and body-worn cameras, bolstered by network effects in the Axon ecosystem.
Risks loom from fiscal pressures on government clients, potentially curbing multi-year contracts, alongside competitive intensification in AI-public safety software. Debt management remains critical, with $1.73 billion in cash supporting investments but requiring disciplined capital allocation. Regulatory scrutiny on law enforcement tech and execution on AI scalability will shape margins, currently at 4.5%. Opportunities arise from international expansion and adjacent markets like drones or VR training. Balanced monitoring of quarterly bookings, SaaS mix (targeting 50%+ of revenue), and macroeconomic fiscal trends will inform strategic positioning amid analyst targets averaging $750.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
AXON in +9.23% Uptrend, rising for three consecutive days on June 02, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AXON advanced for three days, in of 376 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on May 28, 2026. You may want to consider a long position or call options on AXON as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
AXON moved above its 50-day moving average on May 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AXON crossed bullishly above the 50-day moving average on June 01, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 275 cases where AXON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AXON broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.086) is normal, around the industry mean (10.804). P/E Ratio (196.016) is within average values for comparable stocks, (92.218). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.000). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (13.459) is also within normal values, averaging (45.402).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a clinical-stage biopharmaceutical company
Industry AerospaceDefense